Senior Management Profiles

Greg Collier PhD

Managing Director and Chief Executive Officer

Dr Collier has more than 25 years' experience spanning operational, clinical and scientific aspects of pharmaceutical research, development and commercialisation. He has led the planning and execution of multiple commercial transactions, including licensing deals and major M&A activities, and has successfully taken a drug from discovery through to regulatory approval.

Notably, Dr Collier steered ChemGenex Pharmaceuticals from a research-based company with a market capitalisation of $10 million to a company with completed clinical trials and regulatory dossiers submitted to the FDA and EMA. In 2011, Cephalon acquired ChemGenex for $230 million.

Prior to his commercial pharmaceutical career, Dr Collier had an outstanding academic career, highlighted by over 150 peer-reviewed publications and senior authorship on 33 patents. Dr Collier was the inaugural Alfred Deakin Professor at Deakin University, and held positions at Melbourne University, Monash University and University of Toronto. In 2010, Dr Collier was awarded the Roche Award of Excellence for his contribution to the biotechnology industry.

Craig Newton

Chief Operating Officer

Craig Newton has over 30 years' experience in senior business and operational roles in the medical device, pharmaceutical and biotech sectors, among large companies and small start-ups, with activity in Australasia, Asia and Europe.

His experience encompasses marketing, operations and project management across diverse therapeutic areas, including oncology, haematology, cell therapies, fertility and cardiovascular disease. Craig has worked at CSL, Serono UK, Bio Nova International, AVAX Australia and Cryptome Pharmaceuticals, in roles such as Chief Operating Officer, Sales and Marketing Director and Business Unit Manager.

Melanie Farris (GIA) BComn GradDip ACG

CFO and Company Secretary

Melanie is an experienced operations, communications and governance professional, with a strong track record in the planning, management and delivery of strategic corporate projects across industries such as life sciences, investment, agriculture, not-for-profit and music marketing.

Melanie's key experience includes project management of confidential and complex business activities, overall company reporting and compliance with regulatory authorities, restructures, IPOs, M&A and shareholder activities, along with corporate policy development for ASX-listed entities.

Melanie's previous roles include positions in the Office of HRH the Prince of Wales, Global Asset Management, Imperial Cancer Research Fund and The Prince's Foundation. Melanie holds a Bachelor of Communication (Public Relations), and a Graduate Diploma in Applied Corporate Governance. She is an Associate of the Governance Institute of Australia and an Associate of the Institute of Chartered Secretaries (UK).